Positive Interim Data Shows Genentech’s Sefaxersen Significantly Reduces Proteinuria in People With IgA Nephropathy (IgAN)

Go back to Positive Interim Data Shows Genentech’s Sefaxersen Significantly Reduces Proteinuria in People With IgA Nephropathy (IgAN)
Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) Delayed: 59.11 --0 (-0%)
Previous Close $59.11    52 Week High $35.13 
Open $59.11    52 Week Low $28.10 
Day High $59.49    P/E N/A 
Day Low $58.83    EPS $0.00 
Volume 1,311,205